Fred Alger Management, LLC Gilead Sciences, Inc. Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

A detailed history of Fred Alger Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 27,357 shares of GILD stock, worth $2.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

27,357

Previous 27,357 -0.0%

Holding current value

$2.9 Million

Previous $1.88 Million 22.23%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $154,212 - $177,972	2,442 Added 9.8%	27,357 $1.88 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $208,440 - $254,188	2,912 Added 13.23%	24,915 $1.83 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $85,359 - $96,799	1,165 Added 5.59%	22,003 $1.78 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $78,083 - $88,960	1,010 Added 5.09%	20,838 $1.73 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $83,758 - $120,247	1,344 Added 7.27%	19,828 $1.7 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $140,157 - $160,095	2,354 Added 14.59%	18,484 $1.14 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $27,878 - $31,399	483 Added 3.09%	16,130 $997,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $76,744 - $96,168	1,325 Added 9.25%	15,647 $930,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $4,801 - $5,449	74 Added 0.52%	14,322 $1.04 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $12,180 - $13,897	-203 Reduced 1.4%	14,248 $921,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $1.88 Million - $2.36 Million	-30,260 Reduced 67.68%	14,451 $913,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $44.6 Million - $51.8 Million	-616,737 Reduced 93.24%	44,711 $3.44 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $40.5 Million - $51.9 Million	646,665 Added 4374.38%	661,448 $49.5 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $22,335 - $25,046	-361 Reduced 2.38%	14,783 $999,000
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $3.8 Million - $4.26 Million	-60,813 Reduced 80.06%	15,144 $985,000
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $1.51 Million - $1.97 Million	24,939 Added 48.88%	75,957 $4.75 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $2.28 Million - $2.52 Million	31,989 Added 168.11%	51,018 $3.94 Million
Q2 2018 Jul 19, 2018	BUY	$64.88 - $75.68 $177,057 - $206,530	2,729 Added 16.74%	19,029 $1.35 Million
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $874 - $1,065	-12 Reduced 0.07%	16,300 $1.23 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $128,496 - $150,837	-1,806 Reduced 9.97%	16,312 $1.17 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.31 Million - $1.55 Million	18,118	18,118 $1.47 Million

Others Institutions Holding GILD

# of Institutions

2,045

Shares Held

Call Options Held

10M

Put Options Held

9.05M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $133B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Gilead Sciences, Inc. Transaction History